J&J | JNJ - Operating Expenses


J&J reported $18.93B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
AbbVie USD 10.52B 258M Sep/2026
Abbott USD 11.66B 1.2B Sep/2026
Amgen USD 5.69B 6B Sep/2026
AstraZeneca USD 11.55B 674M Sep/2026
Baxter International USD 6.5B 3.82B Sep/2026
Bayer EUR 9.92B 121M Sep/2026
Becton, Dickinson and Co. USD 4.16B 20.25B Sep/2026
Biogen USD 2.32B 663.6M Sep/2026
Boston Scientific USD 4.13B 72M Sep/2026
Bristol-Myers Squibb USD 23.4B 1.08B Sep/2026
CONMED USD 298.41M 8.67M Sep/2026
Cooper Companies USD 844.2M 268.3M Jun/2026
Dexcom USD 990.1M 53.5M Jun/2026
Edwards Lifesciences USD 10.86B 9.64B Sep/2026
Eli Lilly USD 10.52B 496M Jun/2026
Gilead Sciences USD 13.04B 9.09B Sep/2026
GlaxoSmithKline GBP 6.03B 227M Sep/2026
Globus Medical USD 585.49M 250.09M Sep/2026
Insulet USD 652.2M 19.8M Sep/2026
Integra LifeSciences USD 368.53M 674.84M Sep/2026
Intuitive Surgical USD 2B 86.5M Sep/2026
J&J USD 18.93B 1.09B Sep/2026
Medtronic USD 7.92B 203M Jun/2026
Merck USD 10.75B 5.02B Sep/2026
Merit Medical Systems USD 358.44M 20.72M Jun/2026
Novartis USD 9.88B 325M Sep/2026
Pfizer USD 89B 3.81B Sep/2026
Regeneron Pharmaceuticals USD 33.5B 1.79B Sep/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sanofi EUR 10.51B 598M Sep/2026
Stryker USD 4.8B 118M Jun/2026
Tandem Diabetes Care USD 286.06M 17.71M Sep/2026
Teva Pharmaceutical Industries USD 3.18B 733M Sep/2026
Vertex Pharmaceuticals USD 2.18B 118.2M Sep/2026
Zimmer Biomet Holdings USD 1.72B 110.9M Sep/2026
Zoetis USD 3.3B 155M Sep/2026